Interferon_NN
alpha_NN
selectively_RB
affects_VBZ
expression_NN
of_IN
the_DT
human_JJ
myeloid_JJ
cell_NN
nuclear_JJ
differentiation_NN
antigen_NN
in_IN
late_JJ
stage_NN
cells_NNS
in_IN
the_DT
monocytic_JJ
but_CC
not_RB
the_DT
granulocytic_JJ
lineage_NN
._.

The_DT
human_JJ
myeloid_JJ
cell_NN
nuclear_JJ
differentiation_NN
antigen_NN
-LRB-_-LRB-
MNDA_NN
-RRB-_-RRB-
is_VBZ
expressed_VBN
constitutively_RB
in_IN
cells_NNS
of_IN
the_DT
myeloid_JJ
lineage_NN
,_,
appearing_VBG
in_IN
myeloblast_JJ
cells_NNS
in_IN
some_DT
cases_NNS
of_IN
acute_JJ
myeloid_JJ
leukemia_NN
and_CC
consistently_RB
being_VBG
detected_VBN
in_IN
promyelocyte_JJ
stage_NN
cells_NNS
as_RB
well_RB
as_IN
in_IN
all_DT
later_JJR
stage_NN
cells_NNS
including_VBG
peripheral_JJ
blood_NN
monocytes_NNS
and_CC
granulocytes_NNS
._.

The_DT
human_JJ
myeloid_JJ
leukemia_NN
cell_NN
lines_NNS
,_,
HL-60_NN
,_,
U937_NN
,_,
and_CC
THP-1_NN
,_,
express_VBP
similar_JJ
levels_NNS
of_IN
immunochemically_RB
detectable_JJ
MNDA_NN
._.

Although_IN
,_,
the_DT
level_NN
of_IN
MNDA_NN
mRNA_NN
in_IN
primary_JJ
monocytes_NNS
is_VBZ
very_RB
low_JJ
it_PRP
was_VBD
up-regulated_VBN
at_IN
6_CD
h_NN
following_VBG
the_DT
addition_NN
of_IN
interferon_NN
alpha_NN
._.

The_DT
effect_NN
of_IN
interferon_NN
alpha_NN
on_IN
the_DT
MNDA_NN
mRNA_NN
is_VBZ
also_RB
observed_VBN
in_IN
the_DT
cell_NN
lines_NNS
HL-60_NN
,_,
U937_NN
,_,
and_CC
THP-1_NN
._.

The_DT
MNDA_NN
mRNA_NN
level_NN
in_IN
primary_JJ
granulocytes_NNS
was_VBD
unaffected_JJ
by_IN
addition_NN
of_IN
interferon_NN
alpha_NN
and_CC
other_JJ
agents_NNS
including_VBG
interferon_NN
gamma_NN
,_,
endotoxin_NN
,_,
poly_NN
-LRB-_-LRB-
I_NN
-RRB-_-RRB-
._.
poly_NN
-LRB-_-LRB-
C_NN
-RRB-_-RRB-
,_,
and_CC
FMLP_NN
._.

The_DT
MNDA_NN
mRNA_NN
level_NN
in_IN
the_DT
myeloid_JJ
cell_NN
lines_NNS
was_VBD
also_RB
unaffected_JJ
by_IN
the_DT
latter_JJ
four_CD
agents_NNS
._.

Induction_NN
of_IN
differentiation_NN
in_IN
the_DT
myeloid_JJ
cell_NN
lines_NNS
with_IN
phorbol_NN
ester_NN
induces_VBZ
monocyte_NN
differentiation_NN
which_WDT
was_VBD
accompanied_VBN
by_IN
a_DT
decrease_NN
in_IN
MNDA_NN
mRNA_NN
level_NN
._.

This_DT
reduced_VBN
level_NN
of_IN
mRNA_NN
could_MD
then_RB
be_VB
elevated_VBN
with_IN
subsequent_JJ
interferon_NN
alpha_NN
treatment_NN
._.

The_DT
effects_NNS
of_IN
phorbol_NN
ester_NN
on_IN
MNDA_NN
mRNA_NN
appeared_VBD
to_TO
be_VB
associated_VBN
with_IN
induced_VBN
differentiation_NN
since_IN
inhibiting_VBG
cell_NN
proliferation_NN
did_VBD
not_RB
alter_VB
the_DT
level_NN
of_IN
MNDA_NN
mRNA_NN
and_CC
cell_NN
cycle_NN
variation_NN
in_IN
MNDA_NN
mRNA_NN
levels_NNS
were_VBD
not_RB
observed_VBN
._.

The_DT
ability_NN
of_IN
interferon_NN
alpha_NN
to_TO
up-regulate_VB
MNDA_NN
mRNA_NN
in_IN
phorbol_NN
ester_NN
treated_JJ
myeloid_JJ
cell_NN
lines_NNS
is_VBZ
consistent_JJ
with_IN
the_DT
observations_NNS
made_VBN
in_IN
primary_JJ
monocytes_NNS
._.

-LRB-_-LRB-
ABSTRACT_NN
TRUNCATED_VBN
AT_IN
250_CD
WORDS_NNS
-RRB-_-RRB-

